| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.9 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.01 | 0.9 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | -0.0069 | 0.9 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.0087 | 0.9 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0059 | 0.9 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.014 | 0.9 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | 0.0058 | 0.9 |